Subconjunctival application of regenerative factor-rich plasma for the treatment of ocular alkali burns

European Journal of Ophthalmology

Volumn 19, Issue 6, 2009, Pages 909-915

  Del Cid, Rafael Márquez De Aracena ^a,b   Escoriaza, Ignacio Montero De Espinosa ^b  

^a Hospital FREMAP   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Burns; Cornea; Ocular surface; Platelets; Regenerative factor rich plasma

Indexed keywords

AGENTS ACTING ON THE EYE; REGENERATIVE FACTOR RICH PLASMA; UNCLASSIFIED DRUG; ALKALI;

ADULT; ANXIETY; ARTICLE; CAUSTIC BURN; CHEMOSIS; CLINICAL ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; DISEASE DURATION; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG SAFETY; EYE BURN; HEALING; HUMAN; INJECTION SITE STINGING; INTERMETHOD COMPARISON; MALE; MEDICAL LEAVE; PATIENT MONITORING; PRIORITY JOURNAL; SCAR FORMATION; SIDE EFFECT; TOPICAL TREATMENT; TREATMENT RESPONSE; WORK DISABILITY; CHEMICAL BURN; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CORNEA; DISABILITY; DRUG ANTAGONISM; EPITHELIUM CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REGENERATION; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME; WOUND HEALING;

ADULT; ALKALIES; BURNS, CHEMICAL; CONJUNCTIVA; CORNEA; DISABILITY EVALUATION; EPITHELIAL CELLS; EYE BURNS; HUMANS; MALE; PLATELET-RICH PLASMA; REGENERATION; SICK LEAVE; TREATMENT OUTCOME; WOUND HEALING;

EID: 73949135532     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900603     Document Type: Article

References (29)

1. Trusov MS, Rozenkrants KB. Surgical treatment of chemical burns of the eye in combination with irrigation with defibrinated blood and subconjunctival administration of autoblood with antibiotics. Vestn Oftalmol 1966; 79: 61-5.
2. Lenkiewicz E, Ferencowa A, Szewczykowa E. Subconjunctival autohemotherapy of eye burns in our cases. Klin Oczna 1992; 94: 113-4.
3. Kuprianowicz W, Czesnel H. Results of treatment of calcium eye burns with subconjunctival injections of blood. Klin Oczna 1969; 39: 51-4.
4. Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984; 27: 459-61.
5. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-9.
6. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999; 83: 390-5.
7. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001; 20: 807-10.
8. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004; 111: 1115-20.
9. Hartwig D, Herminghaus P, Wedel T, et al. Topical treatment of ocular surface defects: comparison of epitheliotropic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model. Transfus Med 2005; 15: 107-13.
10. Alio JL, Abad M, Artola A, Rodriguez-Prats JL, Pastor S, Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology 2007; 114: 1286-93.
11. Alio JL, Colecha JR, Pastor S, Rodriguez A, Artola A. Symptomatic dry eye treatment with autologous plateletrich plasma. Ophthalmic Res 2007; 39: 124-9.
12. Márquez de Aracena R, Montero de Espinosa I, Muñoz M, Pereira G, Martín F. Tratamiento con concentrado plaquetario plasmático subconjuntival y tópico en el trasplante de limbo. Mapfre Medicina 2006; 17: 280-5.
13. Márquez de Aracena del Cid R, Montero de Espinosa I, Muñoz M, Pereira G. Aplicación subconjuntival de concentrado de plaquetas plasmáticas en el tratamiento de quemaduras oculares. Resultados preliminares. Arch Soc Esp Oftalmol 2007; 88: 475-82.
14. Liu L, Hartwig D, Harloff S, et al. Corneal epitheliotropic capacity of three different blood-derived preparations. Invest Ophthalmol Vis Sci 2006; 47: 2438-44.
15. Hartwig D, Harloff S, Liu L, Schlenke P, Wedel T, Geerling G. Epitheliotropic capacity of a growth factor preparation produced platelet concentrates on corneal epithelial cells: a potential agent fort the treatment of ocular surface defects? Transfusion 2004; 44: 1724-31.
16. Li Z, Rumbaut RE, Burns AR, Smith CW. Platelet response to corneal abrasion is necessary for acute inflammation and efficient re-epithelization. Invest Ophthalmol Vis Sci 2006; 47: 4794-802.
17. Benitez del Castillo JM, Rodriguez-Bayo S, Fontan-Rivas E, Martinez de la Casa JM, Garcia-Sanchez J. Treatment of recurrent corneal erosion with substance P-derived peptide and insulin-like growth factor I. Arch Soc Esp Oftalmol 2005; 123: 1445-7.
18. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmol 2001; 85: 1379-83.
19. World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles fro medical research involving humans subjects. Nurs Ethics 2002; 9: 105-9.
20. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004; 111: 1115-20.
21. Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003; 31: 579-83.
22. Tananuvat N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001; 20: 802-6.
23. Liu L, Li YP, Huang SQ, Lin JX, Zhang WX. Mechanism of keratinocyte growth factor-2 accelerating corneal epithelial wound healing on rabbit alkaline burned cornea. Zhonghua Yan Ke Za Zhi 2005; 41: 364-8.
24. Yam HF, Pang CP, Fan DS, Fan BJ, Yu EY, Lam DS. Growth factor changes in ex vivo expansion of human limbal epithelial cells on human amniotic membrane. Cornea 2002; 21: 101-5.
25. Mathers WD, Sherman M, Fryczkowski A, Jester JV. Dosedependent effects of epidermal growth factor on corneal wound healing. Invest Ophthalmol Vis Sci 1989; 30: 2403-6.
26. Daniele S, Gilbard JP, Schepens CL. Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study. Graefes Arch Clin Exp Ophthalmol 1992; 230: 314-7.
27. Koffler BH. Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel. Ocul Surf 2006; 4: 188-95.
28. Alio JL, Pastor S, Ruiz-Colecha J, Rodriguez A, Artola A. Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma. J Refract Surg 2007; 23: 617-9.
29. Graham GJ, Stevens JM, Page NM, et al. Tachikinins regulate the function of platelets. Blood 2004 104: 1058-65.